tiprankstipranks
Trending News
More News >
Protagonist Therapeutics (PTGX)
NASDAQ:PTGX
US Market
Advertisement

Protagonist Therapeutics (PTGX) Ratios

Compare
685 Followers

Protagonist Therapeutics Ratios

PTGX's free cash flow for Q1 2025 was $1.00. For the 2025 fiscal year, PTGX's free cash flow was decreased by $ and operating cash flow was $-0.68. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
17.26 16.71 7.61 7.74 7.84
Quick Ratio
17.26 16.71 7.62 7.55 7.74
Cash Ratio
3.98 8.78 4.03 2.81 2.92
Solvency Ratio
1.10 -3.56 -0.16 -2.51 -1.46
Operating Cash Flow Ratio
9.60 -3.30 -3.47 -2.45 -1.80
Short-Term Operating Cash Flow Coverage
0.00 0.00 -43.00 -49.03 -49.68
Net Current Asset Value
$ 552.78M$ 334.30M$ -547.33M$ 293.06M$ 270.74M
Leverage Ratios
Debt-to-Assets Ratio
0.02 <0.01 0.01 0.02 0.02
Debt-to-Equity Ratio
0.02 <0.01 >-0.01 -0.01 -0.02
Debt-to-Capital Ratio
0.02 <0.01 >-0.01 -0.01 -0.02
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
1.08 1.06 -0.46 -0.85 -1.14
Debt Service Coverage Ratio
0.00 0.00 -50.65 -54.61 -31.58
Interest Coverage Ratio
0.00 0.00 0.00 0.00 -107.89
Debt to Market Cap
0.00 0.00 <0.01 <0.01 <0.01
Interest Debt Per Share
0.18 0.02 0.07 0.13 0.19
Net Debt to EBITDA
-4.48 2.05 0.93 0.96 1.75
Profitability Margins
Gross Profit Margin
99.28%100.00%96.12%89.86%100.00%
EBIT Margin
16.41%-156.09%-494.24%-460.01%-224.42%
EBITDA Margin
13.79%-150.57%-494.24%-449.87%-222.38%
Operating Profit Margin
13.10%-156.09%-494.24%-460.01%-225.36%
Pretax Profit Margin
27.47%-131.59%-479.26%-458.94%-226.51%
Net Profit Margin
27.04%-131.59%-464.29%-448.25%-231.07%
Continuous Operations Profit Margin
27.04%-131.59%-479.26%-458.94%-231.07%
Net Income Per EBT
98.43%100.00%96.88%97.67%102.01%
EBT Per EBIT
209.69%84.31%96.97%99.77%100.51%
Return on Assets (ROA)
7.57%-22.06%-49.78%-35.27%-20.39%
Return on Equity (ROE)
9.22%-23.45%22.99%29.96%23.31%
Return on Capital Employed (ROCE)
3.85%-27.82%-60.61%-41.44%-22.70%
Return on Invested Capital (ROIC)
3.78%-27.72%-57.39%-39.90%-22.92%
Return on Tangible Assets
7.57%-22.06%-49.78%-35.27%-20.32%
Earnings Yield
1.61%-6.07%-23.07%-7.74%-9.54%
Efficiency Ratios
Receivables Turnover
7.67 5.81 511.17 17.47 11.80
Payables Turnover
0.31 0.00 0.28 1.73 0.00
Inventory Turnover
0.00 0.00 -10.98 0.33 0.00
Fixed Asset Turnover
16.58 27.92 5.75 4.06 4.46
Asset Turnover
0.28 0.17 0.11 0.08 0.09
Working Capital Turnover Ratio
0.37 0.22 0.11 0.10 0.15
Cash Conversion Cycle
-1.15K 62.85 -1.32K 928.86 30.93
Days of Sales Outstanding
47.58 62.85 0.71 20.89 30.93
Days of Inventory Outstanding
0.00 0.00 -33.25 1.12K 0.00
Days of Payables Outstanding
1.19K 0.00 1.29K 210.45 0.00
Operating Cycle
47.58 62.85 -32.53 1.14K 30.93
Cash Flow Ratios
Operating Cash Flow Per Share
5.35 -1.24 -2.20 -2.33 -2.11
Free Cash Flow Per Share
5.33 -1.25 -2.22 -2.35 -2.12
CapEx Per Share
0.03 0.01 0.02 0.02 0.01
Free Cash Flow to Operating Cash Flow
1.00 1.01 1.01 1.01 1.01
Dividend Paid and CapEx Coverage Ratio
203.22 -115.33 -136.02 -97.97 -153.89
Capital Expenditure Coverage Ratio
203.22 -115.33 -136.02 -97.97 -153.89
Operating Cash Flow Coverage Ratio
29.66 -61.56 -29.58 -18.41 -12.16
Operating Cash Flow to Sales Ratio
1.62 -1.17 -4.07 -3.94 -2.53
Free Cash Flow Yield
9.78%-5.44%-20.36%-6.88%-10.52%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
61.50 -16.49 -4.34 -12.92 -10.48
Price-to-Sales (P/S) Ratio
16.37 21.69 20.13 57.91 24.22
Price-to-Book (P/B) Ratio
5.02 3.87 -1.00 -3.87 -2.44
Price-to-Free Cash Flow (P/FCF) Ratio
10.15 -18.37 -4.91 -14.54 -9.50
Price-to-Operating Cash Flow Ratio
10.26 -18.53 -4.95 -14.69 -9.57
Price-to-Earnings Growth (PEG) Ratio
-0.77 0.37 0.88 -0.34 0.29
Price-to-Fair Value
5.02 3.87 -1.00 -3.87 -2.44
Enterprise Value Multiple
114.28 -12.35 -3.14 -11.92 -9.14
Enterprise Value
3.30B 1.12B 412.96M 1.47B 582.03M
EV to EBITDA
115.22 -12.35 -3.14 -11.92 -9.14
EV to Sales
15.88 18.60 15.54 53.60 20.33
EV to Free Cash Flow
9.84 -15.75 -3.79 -13.46 -7.98
EV to Operating Cash Flow
9.80 -15.89 -3.82 -13.60 -8.03
Tangible Book Value Per Share
10.94 5.93 -10.94 6.48 8.13
Shareholders’ Equity Per Share
10.94 5.93 -10.94 -8.84 -8.25
Tax and Other Ratios
Effective Tax Rate
0.02 0.00 0.03 0.02 -0.02
Revenue Per Share
3.30 1.06 0.54 0.59 0.83
Net Income Per Share
0.89 -1.39 -2.52 -2.65 -1.92
Tax Burden
0.98 1.00 0.97 0.98 1.02
Interest Burden
1.67 0.84 0.97 1.00 1.01
Research & Development to Revenue
0.68 2.00 4.75 4.61 2.60
SG&A to Revenue
0.19 0.56 1.19 0.99 0.65
Stock-Based Compensation to Revenue
0.20 0.49 0.91 0.60 0.28
Income Quality
6.00 0.89 0.85 0.86 1.10
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis